Body Fat Distribution and Risk of Cardiovascular Disease: An Update

By J. Despres. Circulation, 2012

1,268 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/b74392bfbf34eb64fe2883383f0daa99c448914b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Rhian M. Touyz
2. Marja-Riitta Taskinen
3. Michael J. Pencina
4. I. Graham
5. Gerhard Hindricks
6. Stephan Windecker
7. I. Neeland

In Public Health, Environmental and Occupational Health

1. I. Graham
2. I. Neeland
3. Douglas G. Altman

Citations in the corpus

• 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. (2019, background): “Hypertension, dyslipidaemia, abdominal obesity, and non-alcoholic fatty liver disease (NAFLD) commonly coexist with T2DM and further aggravate the risk, which is highest in people with T2DM and multiple cardiometabolic risk factors.(406) 408 Importantly, DM confers excess mortality risk following AC”
• 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. (2016, background): “Hypertension, dyslipidaemia and abdominal obesity commonly co-exist with T2DM and further aggravate the risk, which is highest in people with T2DM and features of MetS.(343,344) Importantly, diabetes confers excess mortality risk following ACS despite modern therapies, highlighting the poor prognosi”
• A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association (2023, background): “46 In addition, there are significant racial and ethnic differences in the propensity for metabolic risk factors at a given weight.”